Clinical Edge Journal Scan

Alcoholism and ALDH2 rs671 polymorphism in patients with HBV-related cirrhosis necessitate close monitoring for HCC


 

Key clinical point: Heavy alcohol intake and ALDH2 rs671 polymorphism are associated with a significantly increased risk for hepatocellular carcinoma (HCC) development in patients with hepatitis B virus (HBV)-related cirrhosis.

Major finding: Alcohol intake amount (>160 vs 80-160 g/day: adjusted hazard ratio [aHR] 1.78; P = .04) and ALDH2 rs671 polymorphism (GA/AA vs GG genotype: aHR 5.61; P < .001) were significantly associated with an increased incidence of HCC.

Study details: This retrospective cohort study enrolled 1515 patients with cirrhosis due to heavy alcoholism or HBV infection.

Disclosures: This study was sponsored by the Ministry of Science and Technology, Taiwan, E-Da Hospital-National Taiwan University Hospital Joint Research Program, and others.

Source: Tsai MC et al. Association of heavy alcohol intake and ALDH2 rs671 polymorphism with hepatocellular carcinoma and mortality in patients with hepatitis B virus–related cirrhosis. JAMA Netw Open. 2022;5(7):e2223511 (Jul 25). Doi: 10.1001/jamanetworkopen.2022.23511

Recommended Reading

Advanced HCC: Radiotherapy+anti-PD1 a better therapeutic regimen than TACE+sorafenib
Federal Practitioner
Lenvatinib combination therapy vs monotherapy against HCC: Real-world results
Federal Practitioner
Statin use ties with lower HCC risk in dialysis patients with HBV or HCV monoinfection
Federal Practitioner
Meta-analysis supports the use of direct-acting antiviral therapy in HCV-related HCC
Federal Practitioner
Lenvatinib plus IDADEB-TACE tops lenvatinib monotherapy in advanced HCC
Federal Practitioner
Beta-adrenergic receptor blocker use improves overall survival in HCC
Federal Practitioner
Commentary: HCC With HCV and Treatment Comparisons for Unresectable HCC, August 2022
Federal Practitioner
First-line LEN-TACE: A potential treatment for advanced HCC
Federal Practitioner
Liver Transplant for HCC: Long-term outcome of downstaging to within Milan criteria support national downstaging policy
Federal Practitioner
Liver Transplant for HCC: Long-term outcome of downstaging to within Milan criteria support national downstaging policy
Federal Practitioner